Intra Cellular Therapies reported $625.7M in Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US $ 724.43M 30.74M
Adamas Pharmaceuticals ADMS:US 150.64M 18.6M
ALKERMES ALKS:US $ 1937.57M 59.35M
Aptinyx Inc APTX:US $ 134.17M 18.72M
Arena Pharmaceuticals ARNA:US $ 1084.66M 99.28M
Biocryst Pharmaceuticals BCRX:US $ 277.28M 7.15M
Biogen BIIB:US $ 24470.4M 615.7M
Bristol Myers Squibb BMY:US $ 110797M 1638M
Cytokinetics CYTK:US $ 564.3M 12.76M
Esperion Therapeutics ESPR:US $ 280.46M 1.86M
Gilead Sciences GILD:US $ 67984M 492M
Gw Pharmaceuticals GWPH:US $ 934.34M 5.17M
Halozyme Therapeutics HALO:US $ 1025.86M 59.28M
Intra Cellular Therapies ITCI:US $ 625.7M 48.79M
JAZZ PHA JAZZ:US $ 13212.99M 6456.52M
Marinus Pharmaceuticals MRNS:US $ 124.99M 8.87M
Minerva Neurosciences NERV:US $ 105.32M 6.51M
Nektar Therapeutics NKTR:US $ 1371.35M 85.21M
Neurocrine Biosciences NBIX:US $ 1956.4M 110M
Novartis NVS:US $ 124015M 2263M
Prothena PRTA:US $ 436.38M 56.66M
Redhill Biopharma RDHL:US $ 203.67M 16.45M
Supernus Pharmaceuticals SUPN:US $ 1573.06M 65.62M
United Therapeutics UTHR:US $ 4844.9M 203.9M
Vanda Pharmaceuticals VNDA:US $ 567.64M 24.45M
Zogenix ZGNX:US $ 540.07M 40.89M